Lithium Energy Limited (ASX:LEL) Announces Amended Solaroz Sale and Axon Graphite Spin-Out
Lithium Energy Limited (ASX:LEL) amends the sale of its Solaroz project and plans to spin out Axon Graphite through a shareholder-approved IPO.
Tag: Regulatory News & Compliance
Echo IQ Limited (ASX:EIQ) Submits Pre-Submission Meeting Request with US FDA
Echo IQ Limited (ASX:EIQ) submits a pre-submission meeting request with the US FDA for its heart failure solution, EchoSolv HF, progressing towards market entry in H2 2025.
Saferoads Holdings Limited (ASX:SRH) Releases Q4 Activities Report
Saferoads Holdings Limited (ASX:SRH) reports a slight revenue decrease in Q4, significant debt reduction, and progress on business sale and product approvals.
Conico Ltd (ASX:CNJ) Releases December 2024 Quarterly Report
Conico Ltd (ASX:CNJ) releases December 2024 Quarterly Report, detailing project updates and legal disputes.
Alchemy Resources Limited (ASX:ALY) Releases Quarterly Cash Flow Report
Alchemy Resources Limited (ASX:ALY) reports a quarterly net cash outflow of $15,000 in operating activities and $533,000 in investing activities, ending the quarter with $2.003 million in cash.
Renascor (ASX:RNU) Advances BAM and PSG Projects, Extends Major Project Status
Renascor (ASX:RNU) reports significant progress on BAM and PSG projects, exceeds production targets, and extends Major Project Status.
NuCoal Resources Ltd (ASX:NCR) Criticises NSW Premier’s Stance on Compensation
NuCoal Resources Ltd (ASX:NCR) criticises the NSW Premier’s refusal of compensation related to the Mining Amendment Act and plans to seek further actions.
Ark Mines Ltd (ASX:AHK) Reports Q4 Activities and Exploration Progress
Ark Mines Ltd (ASX:AHK) announced its Q4 activities report, highlighting significant exploration upgrades and future development plans for Sandy Mitchell Project.
Novonix (ASX:NVX) Secures $754 Million DOE Loan and Signs Strategic Offtake Agreements
Novonix (ASX:NVX) secures a $754M DOE loan from the US Department of Energy and signs significant offtake agreements with Stellantis and PowerCo, enhancing its position in the battery supply chain.
Clarity Pharmaceuticals (ASX:CU6) Releases Q4 Activity Report
Clarity Pharmaceuticals (ASX:CU6) reports strong Q4 financials, significant trial progress, and entry into the ASX200 index.